Welcome to the Dallas Surgical Group website.  Our specialty is dealing with cancer and surgical oncology.  Our chief physician is Dr. Peter Beitsch, who is widely recognized for excellence in surgical oncology, breast cancer surgery and the care of the patient with all stages of melanoma.  Our mission is to provide you with the most accurate, innovative, and technologically advanced surgical management of cancer care in Dallas, Texas.  If you are in the Southwest or anywhere in the US and need advanced treatment modalities we encourage you to contact us.

We’ve moved!

Come see us at our new location:

8140 Walnut Hill Lane
Suite 800
Dallas, TX 75231
(inside the One Glen Lakes Building, one stop light east of Hwy 75, behind MHBT building)


Dr. Beitsch named as one of the top cancer doctors in America by Newsweek! The award takes into account his reputation among his peers, his patients, his education/training, and research.


You can also connect with us on Facebook and Twitter

{ 1 comment }

Here’s a recent article from Dr Beitsch:



Are there any models or measurements to measure the risk of melanoma?

September 7, 2012

The American Joint Commission on Cancer or AJCC has a staging system for all cancers including melanoma. Using melanoma thickness, the presence or absence of lymph node metastasis and presence or absence of systemic (body) spread, the staging system will place you in a Stage that corresponds to a percentage of patients who survival for […]

Read the full article →

American Society of Breast Surgeons Annual Meeting in Phoenix 2012 – Highlights

June 4, 2012

There were numerous records set at this year’s meeting – most abstracts submitted, most poster presentations, most scientific papers and highest number of breast surgeons – over 1200!! Many presentations attrached attention but here are a few of my favorite ones. 1)  Thermography, basically a heat mapping of each breast, has been performed for >40 […]

Read the full article →

Physicians React to MD Anderson Study on Partial Breast Radiation

December 15, 2011

The study out of MD Anderson reporting ‘double the mastectomy rate’ for patients treated with accelerated partial breast irradiation compared to whole breast irradiation, has created a tremendous amount of angst in the lay and medical press.  Studies such as these that rely on large retrospective databases can provide interesting data although it all depends […]

Read the full article →

15 years ago 100% of women had complete node dissection now only 10% – that’s progress!

October 26, 2011

“Before the advent of sentinel node biopsy essentially all women with invasive cancer had to have a complete axillary lymph node dissection…. So in the course of less than 15 years, we have gone from 100% of women with invasive cancer having a complete dissection to around 10% – that is tremendous progress in lessening […]

Read the full article →

Breast Cancer Prevention in Postmenopausal Women

September 8, 2011

A study presented at the annual meeting of the American Society of Clinical Oncology and published online by the NEJM indicates Exemestane, which is now used to prevent recurrences of breast cancer, can also reduce the risk of it occurring in the first place. To read the full text you can go to:  http://www.nejm.org/doi/full/10.1056/NEJMoa1103507

Read the full article →